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Background: The correct methodology of thrombelastography might be influenced by elapsing time. In our study
we investigated kaolin activated citrated samples together with non-activated citrated samples in relation to the
elapsed times of 0, 15 and 30 minutes to compare both methods and to find out if there is an impact of time on
results of thrombelastography.
Methods: Blood samples obtained from 10 healthy volunteers were analyzed after 0, 15 and 30 minutes from
sampling with kaolin activation and without activation. Then the results were analysed and compared between the
non-activated and the kaolin-activated method.
Results: All blood samples became more hypercoagulable with the time elapsing, both in non-activated and
kaolin-activated samples and differences between both groups were found statistically and clinically significant after
only 0 minutes.
Conclusions: The non-activated citrated method seems to be reliable and suitable for thrombelastography in
non-emergency cases (planned surgical procedures) when we have time to wait 15–30 minutes to get results. In
urgent situations a rapid thrombelastography test should be preferred. Although the kaolin-activated method can
also be used, results must be interpreted with caution.
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Thrombelastography (TEG) has been used as a laboratory
and bed-side method since 1948 [1]. However, it still has
some inconveniences as do many of the methods being
used when working with TEG, thus bringing a bit of chaos
to the methodology and one of reasons to get faster re-
sults. Each hospital has its own method and that is why
results cannot be compared among hospitals and experi-
ences cannot be shared. Many methods have been intro-
duced to practice such as the non-activated native and the
kaolin-activated native method, as well as non-activated
citrated and kaolin-activated citrated method and rapid
TEG test. Other substances are also used to activate the
sample, such as celite and tissue factor. Every method has
advantages and disadvantages. The disadvantage of using
the native method is the necessity to perform an analysis* Correspondence: durila4@gmail.com
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unless otherwise stated.within 4–5 minutes from the sampling. This time period
is very unpractical, especially during the admission of a
patient in critical condition in the intensive care unit
(ICU). Preparing a TEG machine requires our full atten-
tion and this time interval is often insufficient. A five mi-
nute interval is also insufficient to transport a sample
from the operating theatre to the lab or to the place where
a TEG is available. Therefore, the citrated method has
been developed and is preferred by many authors [2-7].
Because the generation of TEG trace using non-activated
citrated blood is slow, the addition of activators has been
proposed to speed up the process. Kaolin is increasingly
used for this purpose [2,8,9]. However, kaolin not only ini-
tiates the intrinsic coagulation pathway but has complex
effects on platelets. It activates platelets by releasing plate-
let factor 3 [10] and can also inflict the clot to retract and
mimic the fibrinolysis pattern [11] and so mislead doctors
to the incorrect therapy. On the other hand, citrated sam-
ples are not stable over time and results are more hyperco-
agulable with the time elapsing [12]. ThromboelastographyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Differences of parameters in citrated non-activated (CN) group among 0, 15, 30 minutes. Little sign means statistical differences and
error bars represent SD. R – reaction time, time from the start of the sample run to the first detectable clot formation (amplitude =2 mm); K – time
from R to the clot amplitude of 20 mm (to specify the kinetics of the clot development); alfa angle, the angle formed by the slope between the
amplitude of the trace at 2 mm and 20 mm; MA, maximum clot amplitude; CI, coagulation index; LY 30 and LY 60, level of fibrinolysis at 30 and
60 min, respectively, after MA was reached. * means significant differences between CN 0 min vs. CN 15 min and between CN 0 min vs. CN
30 min, p < 0.05; # means significant difference between CN 0 min vs. CN 30 min, p < 0.05; x means non-significant difference between CN 15
min vs. CN 30 min, p > 0.05.
Durila et al. BMC Anesthesiology  (2015) 15:50 Page 3 of 7users might take advantage of the time effect in non-
activated samples (without kaolin) to produce more cost-
effective and consistent TEG results in non-emergency situ-
ations such as planned surgical interventions. This could be
useful to reduce fresh frozen plasma administering (FFP) in
patients with prolonged prothrombin time.
We decided to compare the results of kaolin activated
citrated samples with results of non-activated sample in
relation with elapsed time of 0, 15 and 30 minutes. We
wanted to find out if time impacts the activation of citrated
samples. The time period of 15 to 30 minutes would be
very practical for transporting blood samples to lab. It is
very important to elaborate the TEG method, which could
be used in non-emergency situations (such as planned sur-
gical procedures) especially in patients with intensive care
unit (ICU) coagulopathy represented by prolonged pro-
thrombin time (PT) because TEG as a global coagulation
test may lead to reduced FFP transfusion administered pre-
ventively (before surgery) just on the base of prolonged PT
and thus minimize related adverse side effects of FFP [13].
Methods
This study was approved by the Ethics Committee for
Multi-Centric Clinical Trials of the University Hospital
Motol (date of approval March 2008, Reference No.
EK425/08) and written informed consent was obtained
from all subjects.
In the first step of study we investigated the role of
time and its influence on the stability of blood samples
after 0, 15 and 30 minutes in both non-activated citrated
and kaolin activated citrated samples. Blood was ob-
tained from 10 healthy volunteers (5 men and 5 women,
from 20 to 30 years, non-smokers, not taking contracep-
tive pills, no bleeding disorder history) from the cubital
vein using a 10 ml syringe and needle and blood was
squirted into 3 citrated tubes with a volume of 2 ml
(Vacuette, 9 NC Coagulation Sodium Citrate 3.2%, Greiner
Bio-One GmbH, Austria). Immediately after obtaining
blood (and gentle mixing the blood sample 5–6 times) -
after 0 minutes, 1 ml of blood was poured from the first
2 ml citrated tube to the kaolin vial and after 3–4 minutes
340 μl of this blood was pipetted to the cuvette containing
20 μl of calcium (0.2 M CaCl2, TEG Hemostasis System,
Haemoscope Corp., USA) and the sample was started.
Meanwhile (after 2–3 minutes from sampling) 340 μl ofblood was pipetted from the citrated tube to the other cu-
vette containing 20 μl of calcium and the non-activated
sample was initiated. After 15 minutes the second 2 ml
citrated tube was used and the process was repeated. After
30 minutes the third 2 ml citrated tube was used and the
process was repeated again. Three TEG machines were
used simultaneously in this study (6 channels used alter-
nately, at 37°C, TEG Haemoscope, Niles, Illinois, USA).
In the second step we compared the results between
non-activated and kaolin-activated method after 0, 15
and 30 minutes.Statistical analysis
GraphPad Prism was the statistics program used in our
study. After data testing for normality using the D’Agostino
& Pearson omnibus normality test, a repeated measures
ANOVA (analysis of variance) was used to compare the ef-
fect of time on sample stability. Then in post hoc analysis
the Tukey test was used. In the second step to compare
non-activated with kaolin-activated, a paired t-test was used
(p < 0.05 was considered significant).Results
In all measurements, both non-activated and kaolin acti-
vated, the time elapsed from blood sampling played a
role and the samples became more hypercoagulable. The
most significant time effect (p < 0.05) occurred within
the first 15 minutes (between 0 and 15 minutes) both
for non-activated and kaolin activated samples. After 15
minutes (between 15 and 30 minutes) time does not
seem to play a significant role and the results do not
differ significantly (p > 0.05) in either group (Figures 1
and 2). Interestingly, we found that CI in the non-
activated method was nearest to 0 after 15 minutes
whereas in kaolin-activated method was nearest to 0
after 30 minutes (Figures 1 and 2).
In the second step we compared the results of non-
activated samples with the results of kaolin-activated
samples of all time points 0, 15, 30 minutes. Significant
differences (p < 0.05) between non-activated and kaolin-
activated samples were found mostly in 0 group for pa-
rameters R, K and alfa angle (Figure 3). After elapsing
15 and 30 minutes, there was no significant difference in
TEG parameter (Figure 3) (p > 0.05).
Figure 2 (See legend on next page.)
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Figure 2 Differences of parameters in citrated kaolin-activated (CK) group among 0, 15, 30 minutes. Little sign means statistical differences and
error bars represent SD. R – reaction time, time from the start of the sample run to the first detectable clot formation (amplitude =2 mm);
K – time from R to the clot amplitude of 20 mm (to specify the kinetics of the clot development); alfa angle, angle formed by the slope between
the amplitude of the trace at 2 mm and 20 mm; MA, maximum clot amplitude; CI, coagulation index; LY 30 and LY 60, level of fibrinolysis at 30
and 60 min, respectively, after MA was reached. * means significant differences between CK 0 min vs. CK 15 min and between CK 0 min vs. CK
30 min, p < 0.05; # means significant difference between CK 0 min vs. CK 30 min, p < 0.05; x means non-significant difference between CK
15 min vs. CK 30 min, p > 0.05.
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Many studies have been done to investigate the time in-
fluence on sample stability, especially after 30 minutes
to many hours elapsed from sampling, using the citrated
method with either non-activated or kaolin activated
samples [4,8,14,15]. In this study we investigated sample
stability after 0, 15 and 30 minutes from sampling also
in both activated and non-activated citrated samples. In
practice this is the most interesting time because it is
sufficient to transfer the sample to the laboratory and
prevents redundant delay.
In both the non-activated and the kaolin-activated
method, we found a tendency of hypercoagulability de-
pending on the time elapsed from blood sampling. This
is consistent with the findings of Camenzind who found
that citrate does not completely inhibit thrombin forma-
tion [12]. The biggest impact of time effect was detected
between 0 and 15 minutes in both methods (Figures 1
and 2). Afterwards there was no significant effect of time
on coagulation. That means that blood samples can be
analyzed between 15–30 minutes using both methods.
This time is sufficient to transfer a blood sample from
the patient to the lab where it can be analyzed. This
laboratory usage of the TEG method may be sufficient
and suitable for non-emergency cases where it is pos-
sible to wait some time for results, for example before
planned surgical interventions (especially with ICU
coagulopathy-prolonged PT). Thus it can help in de-
creasing the unnecessary administration of FFP which is
usually administered preventively before surgery in case
of prolonged PT. It is also recommended by other
authors to wait at least 15 to 30 minutes to reach equili-
bration of the citrated blood sample before running
TEG [12].
Our findings are also in accordance with results of
White who did not find significant differences between
results obtained after 15 and 30 minutes using the
kaolin-activated citrated method [8]. Interestingly, our
data obtained from healthy volunteers is very similar to
his obtained from ICU patients who were even on anti-
coagulants and using arterial blood. The question re-
mains, which time point is the best for analyses. Our
volunteers are healthy and thus we believe that they do
not have a tendency towards hypocoagulability or hyper-
coagulability and their CI is 0. As the CI in the non-activated method was nearest to 0 after 15 minutes, we
believe that this time is the best for stabilization of
the sample to get the most valid data. As the CI in
kaolin-activated method was nearest to 0 after 30 mi-
nutes, this time period seems to be adequate for sample
stabilization before analysis. However, as kaolin not only
initiates the intrinsic coagulation pathway but as well ac-
tivates platelets by releasing platelet factor 3 [10] and
thus can inflict the clot to retract and mimic the fibrin-
olysis pattern [11], the non-activated method seems to
be not only cheaper but also more reliable. The fibrin-
olysis TEG curve can be explained paradoxically by clot
retraction which is accompanied by an increase of ten-
sile strength. During this process formed fibrin filaments
interacting with platelets are connecting the pin and cu-
vette. As soon as the retraction is so vehement that fila-
ments start to break and disconnect the pin from the
cuvette, it is detected by the TEG as a loss of resistance
thus imitating fibrinolysis.
Another interesting finding of the study is that time and
kaolin do not seem to have an effect on the parameters of
fibrinolysis, although in one of our case reports we de-
scribe the effect of kaolin on the fibrinolysis pattern- in
reality retraction of coagulum [11]. In the second step we
investigated the relationship between results of non-
activated citrated blood samples with results of kaolin-
activated citrated blood samples of time points 0, 15, 30
minutes (groups analysed after 0, 15, 30 minutes from
sampling). Surprisingly, significant differences were found
mostly in the 0 time point group where the blood sample
was analyzed immediately after sampling (after 0 minutes)
(Figure 3). In the 15 and 30 minutes groups there were no
differences in parameters. Therefore it could be rational to
use time activation method in all cases when we have time
to wait 15–30 minutes to get reliable results without using
kaolin, thereby to get results not influenced by kaolin,
which costs $5 US. This should also be confirmed in ICU
patients and a new reference range for this time interval
would also be reasonable.
The limitation of the study is that we analysed blood
from healthy volunteers. Different situations may be
observed in sick patients. Jabel et al. demonstrated that
in ECMO patients citrated samples (kaolin activated)
could produce an apparent heparin reversal effect [16].
This seems to be another reason why the native method
Figure 3 Differences between citrated non-activated (CN) and citrated kaolin-activated (CK) method for each parameter after 0, 15 and 30 minutes.
Little sign means statically significant differences between methods within the same time group and error bars represent SD. R – reaction time, time
from the start of sample run to the first detectable clot formation (amplitude =2 mm); K – time from R to the clot amplitude of 20 mm (to specify the
kinetics of the clot development); alfa angle, angle formed by the slope between the amplitude of the trace at 2 mm and 20 mm; MA, maximum clot
amplitude; LY 30 and LY 60, level of fibrinolysis at 30 and 60 min, respectively, after MA was reached. * means p < 0.05; ** means p < 0.01; *** means
p < 0.001. Manufacturer references for citrated non-activated method: R 9–27 minutes, K 2–9 minutes, alfa angle 22–58 degrees, MA 44–64 mm, LY 30
0-8%, LY 60 0-15%. Manufacturer references for citrated kaolin-activated method: R 2–8 minutes, K 1–3 minutes, alfa angle 55–78 degrees, MA 51–69
mm, LY 30 0-8%, LY 60 0-15%.
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hand, Moreland et al. demonstrated artificial fibrinolysis
when citrated samples were used in the heparinase TEG
cups [17]. As well, we have published the observation
that the heparinase method can mimic fibrinolysis even
in native blood (not citrated blood), but in reality it is
the hyperretraction of coagulum [18].A second limitation that has to be mentioned is that
the observed time effect found in healthy volunteers will
need to be confirmed in ICU patients before assuming
that the time effect would lead to equivalent results in
this population.
The relatively small sample size of the study (10 vol-
unteers) considering the relative large interindividual
Durila et al. BMC Anesthesiology  (2015) 15:50 Page 7 of 7variability of TEG data is another limitation of the study.
However differences were statistically significant.
Conclusions
In conclusion, the time activation of the blood sample
plays an important role in thrombelastography both in the
kaolin activated and the non-activated method citrated
method. Non-activated citrated TEG method used be-
tween 15–30 minutes from sampling seems to be reliable
and suitable for analysing blood coagulation in haematol-
ogy lab. This may be especially appropriate when TEG is
used for whole blood coagulation assessment in patients
with ICU coagulopathy (prolonged PT) before planned
surgical intervention when FFP is administered prevent-
ively. This method of using TEG can help in decreasing
often unnecessarily administered FFP.
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